Several candidates relegated to the R&D graveyard re-emerged from their tombs this year and now headline the pharma developmental slate for 2020.
MM&M estimates that revenue for the growing conglomerate increased 7.6% in 2018, to an estimated $245 million from 2017’s sum of $227.8 million.
Triple Threat Communications founder and leader Tim Frank makes it a point to mind the culture — which, he says, is all about putting clients first.
Revenue jumped to $6.4 million in 2018 — a 156% increase.
Revenue grew from $4.7 million in 2017 to $9.8 million in 2018.
Relevate Health Group saw a 4.9% bump in revenue, from $14.2 million to $14.9 million.
Within its healthcare vertical, P+N’s revenue jumped 23.7%, from $5.9 million at the end of 2017 to $7.3 million by the close of 2018.
For Pacific Communications president Craig Sullivan, 2018 provided ample cause for celebration.
MEI increased revenue to $29 million from $26 million in 2017, an 11.5% surge.
MedThink’s revenue climbed 22.4% to $15.3 million.
MM+M is proud to announce the fourth annual Pinnacle Awards program, which celebrates the medical marketing industry’s most venerable marketers, strategists and creators.
Get the most out of
Register for free and enjoy unlimited access to: